UK government missing healthy ageing targets and must act now – report

The COVID-19 pandemic has highlighted stark inequalities in healthy life expectancy, according to a report into ageing published on Friday 15 January. The report into healthy ageing has been published by the House of Lords Science and Technology Committee, following an in-depth inquiry for which the University of Birmingham’s Professor Janet Lord was Special Adviser. The report … Continue reading “UK government missing healthy ageing targets and must act now – report”

How do different mutations in the same gene cause different types of cancer?

Leading cancer experts at BHP founder member the University of Birmingham have solved a long-standing question of how various types of mutations in just one gene cause different types of diseases. A team of scientists at the University’s Institute of Cancer and Genomic Sciences, led by Professor Constanze Bonifer, studied a gene known as RUNX1, which … Continue reading “How do different mutations in the same gene cause different types of cancer?”

Why do breastfed babies have better immune systems?

BHP research led by our founding members the University of Birmingham and Birmingham Women’s and Children’s NHS Foundation Trust, has revealed new insight into the biological mechanisms of the long-term positive health effects of breastfeeding in preventing disorders of the immune system in later life. Breastfeeding is known to be associated with better health outcomes … Continue reading “Why do breastfed babies have better immune systems?”

Attitudes to vaccines revealed in new Midlands study

A recent survey undertaken by Dr Anandadeep Mandal (Birmingham Business School) and Professor Paul Moss, Deputy Head of College of Medical and Dental Sciences, hopes to influence government policy on vaccine hesitancy. It is believed to be the largest and first cross-sectional survey in the UK to examine the various factors influencing the uptake of a potential approved … Continue reading “Attitudes to vaccines revealed in new Midlands study”

Promising results for glaucoma patients as researchers work towards injection-free treatment

Scientists at BHP founder-member the University of Birmingham have shown that a novel low molecular weight dextran-sulphate, ILB® could play a key role in treating open angle glaucoma (OAG), a neurodegenerative disease that affects over 70 million people worldwide and causes irreversible blindness. OAG develops slowly over many years.  Excessive matrix deposition (fibrosis) within the … Continue reading “Promising results for glaucoma patients as researchers work towards injection-free treatment”